JPMorgan Chase & Co’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $369 | Sell |
74
-1,031
| -93% | -$5.14K | ﹤0.01% | 5837 |
|
|
2025
Q1 | $8.85K | Buy |
1,105
+1,103
| +55,150% | +$8.84K | ﹤0.01% | 5466 |
|
|
2024
Q4 | $15 | Hold |
2
| – | – | ﹤0.01% | 6239 |
|
|
2024
Q3 | $19 | Hold |
2
| – | – | ﹤0.01% | 6183 |
|
|
2024
Q2 | $25 | Hold |
2
| – | – | ﹤0.01% | 6118 |
|
|
2024
Q1 | $44 | Hold |
2
| – | – | ﹤0.01% | 6048 |
|
|
2023
Q4 | $18 | Buy |
+2
| New | +$18 | ﹤0.01% | 6320 |
|
|
2023
Q3 | – | Sell |
-54
| Closed | -$4.62K | – | 6480 |
|
|
2023
Q2 | $4.62K | Buy |
+54
| New | +$4.62K | ﹤0.01% | 5289 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5790 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | -$1K | – | 5517 |
|
|
2022
Q2 | $1K | Sell |
1
-9
| -90% | -$9K | ﹤0.01% | 5466 |
|
|
2022
Q1 | $21K | Sell |
10
-7
| -41% | -$14.7K | ﹤0.01% | 5253 |
|
|
2021
Q4 | $83K | Buy |
17
+10
| +143% | +$48.8K | ﹤0.01% | 4900 |
|
|
2021
Q3 | $44K | Sell |
7
-14
| -67% | -$88K | ﹤0.01% | 4988 |
|
|
2021
Q2 | $195K | Sell |
21
-19
| -48% | -$176K | ﹤0.01% | 4508 |
|
|
2021
Q1 | $352K | Buy |
40
+6
| +18% | +$52.8K | ﹤0.01% | 4217 |
|
|
2020
Q4 | $256K | Buy |
34
+25
| +278% | +$188K | ﹤0.01% | 4068 |
|
|
2020
Q3 | $57K | Hold |
9
| – | – | ﹤0.01% | 4252 |
|
|
2020
Q2 | $66K | Sell |
9
-7
| -44% | -$51.3K | ﹤0.01% | 4114 |
|
|
2020
Q1 | $113K | Sell |
16
-3
| -16% | -$21.2K | ﹤0.01% | 3905 |
|
|
2019
Q4 | $287K | Sell |
19
-9
| -32% | -$136K | ﹤0.01% | 3689 |
|
|
2019
Q3 | $269K | Buy |
28
+3
| +12% | +$28.8K | ﹤0.01% | 3614 |
|
|
2019
Q2 | $355K | Buy |
25
+21
| +525% | +$298K | ﹤0.01% | 3517 |
|
|
2019
Q1 | $60K | Buy |
+4
| New | +$60K | ﹤0.01% | 4167 |
|